SUBSCRIBE
SUBSCRIBE
News   Business

Cannasat Therapeutics Inc. Reports Results for the Six Months Ended June 30, 2008

September 2, 2008 | 
1 min read

TORONTO, ONTARIO--(Marketwire - August 29, 2008) - Cannasat Therapeutics Inc. (TSX VENTURE: CTH), a CNS drug development company, today announced its results for the six months ended June 30, 2008.

Earnings
MORE ON THIS TOPIC
Correct decision chosing - confused man character standing on the crossroads and looking at signpost with three different directions - conceptual vector illustration
Depression
Relmada Considering ‘Strategic Alternatives’ After Failure of Depression Asset
December 9, 2024
 · 
1 min read
 · 
Heather McKenzie
Pictured: Eli Lilly's biotechnology center in California
Manufacturing
Lilly Pumps $3B Into Wisconsin Site as Compounders Close In on Tirzepatide
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Manufacturing
Amgen to Add 370 New Jobs in North Carolina With $1B Manufacturing Investment
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Funding
Nuvig Ropes in $161M Series B From Big Pharma Players for Autoimmune Indications
December 5, 2024
 · 
1 min read
 · 
Kate Goodwin